Core Laboratories Inc. 8-K Summary
Business Context and Reporting Period
Core Laboratories Inc. (NYSE: CLB) filed a Current Report on Form 8-K on October 23, 2024. The filing serves to disclose the company's financial results for the third quarter of 2024 and the declaration of a quarterly cash dividend.
Key Financial Metrics
The filing text references the issuance of a press release containing third-quarter 2024 financial results but does not explicitly state specific values for revenue, profit, cash flow, margins, debt, or liquidity within the 8-K document itself. These metrics are contained in the attached Exhibit 99.1 (Press Release).
Material Changes and Dividend Declaration
- Dividend Declaration: The Board of Directors declared a quarterly cash dividend of $0.01 per share of common stock.
- Record Date: November 4, 2024.
- Payment Date: November 25, 2024.
Guidance, Outlook, and Risks
The 8-K filing does not contain specific management commentary, forward-looking guidance, risk factors, or details on unusual items. It directs readers to the press release (Exhibit 99.1) for the full text of the financial announcement. The filing includes a standard disclaimer that the information in the report and exhibit is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2024 revenue, earnings per share, and cash flow figures.
- Verify the dividend payment schedule and eligibility based on the November 4, 2024 record date.
- Check for any updated full-year 2024 guidance provided in the accompanying press release.
- Confirm the company's liquidity position and debt levels as detailed in the full financial results.